On the BRINK: PhotoBiomodulation (PBM) for Mucositis in Patients Undergoing Allogeneic Hematopoietic Stem Cell TRansplant (HSCT) - Implementing the Evidence & Discovering New Knowledge

City of Hope

Status: Active, not recruiting

Conditions: Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm

Treatments: Other: Non-Interventional Study

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT06625619

NCI-2024-01324 (Registry Identifier)

P30CA033572 (U.S. NIH Grant/Contract)

23673 (Other Identifier)

Details and patient eligibility

About

This study evaluates mucositis and other oral symptoms in patients undergoing photobiomodulation in patients undergoing hematopoietic stem cell transplantation.

Full description

PRIMARY OBJECTIVE:

I. Examine mucositis severity, oral pain, taste changes, and xerostomia in patients undergoing PBM, a new standard of care for oral mucositis.

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.

GROUP I: Patients have their medical records reviewed on study.

GROUP II: Nurses complete surveys on study.

Enrollment: 6 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• PATIENTS:

  • Age: ≥ 18 years
  • Undergoing allogeneic HSCT - cases where PBM was used and cases where PBM was not used

NURSES:

• Nurses who administer PBM

Trial design

6 participants in 2 patient groups

Group I (Patients)

Description:

Patients have their medical records reviewed on study.

Treatment:

Other: Non-Interventional Study

Group II (Nurses)

Description:

Nurses complete surveys on study.

Treatment:

Other: Non-Interventional Study